NOTICE OF INTENT TO SOLE SOURCE Allergen Extract Products.pdf

PDF 396 KB Posted

Attached to
Notice of Intent to Sole Source: Allergen Extract Supplies
Solicitation number
W81K04-25-R-A010
Issued by

About this file

This is a Notice of Intent to Sole Source issued by the Health Readiness Contracting Office at JBSA Fort Sam Houston for allergen extract stock solutions and related supplies to support the United States Army Centralized Allergen Extract Laboratory at Fort Meade, MD. The government intends to execute a sole source award under FAR 6.302-1, with an anticipated award date of August 15, 2025.

The requirement is for allergen extract stock solutions covering trees, grasses, weeds, molds, food, animals and other antigens, along with vials, syringes and ancillary supplies. The contract will be a Firm Fixed Price award with a base year plus four option years (August 2025 - August 2030), with a possible 6-month extension through February 2031. The base year value is estimated at $1.8M. The NAICS code is 325412 with a size standard of 1,300 employees. Interested parties must be FDA-approved and licensed, comply with USP 797 guidelines, and be able to supply at least 98% of requested allergen extracts. Responses are due by March 4, 2025 at 12:00 PM CST.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

NOTICE OF INTENT TO SOLE SOURCE

The Health Readiness Contracting Office, located at 2199 Storage Street, Suite 68 JBSA Fort Sam Houston, Texas 78234 is issuing this Notice of Intent (NOI) to inform industry contractors of the Government’s intent to execute a Sole Source Award under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements under the authority of 10 U.S.C. 3204 (c)(1).

The contractor shall supply allergen extract stock solutions for a wide variety of allergens, including but not limited to trees, grasses, weeds, molds, food, animals and miscellaneous antigens; vials, syringes and other related ancillary supplies in support of the United States Army Centralized Allergen Extract Laboratory (USACAEL), Kimbrough Ambulatory Care Center (KACC), Fort Meade, MD.

This procurement is being conducted using FAR Part 15, Contracting by Negotiation, allowing the Contracting Officer (KO) to solicit from one source. This will be a Firm Fixed Price (FFP) award and an anticipated award date is set for August 15, 2025.

The period of performance, including base year and four-year contract estimated from 16 August 2025 - 15 August 2030. FAR Clause 52.217-8, Option to Extend Services will be included in the contract to allow for an additional 6-month extension, if needed, from 16 August 2030 through 15 February 2031.

Total estimated value for the Base is $1.8M.

The North American Industry Classification System (NAICS) for this requirement is, 325412, Pharmaceutical Preparation Manufacturing. The Small Business Administration (SBA) size standard for this sector is 1,300 employees.

This notice of intent is neither a formal solicitation nor a request for competitive proposals. No solicitation document is available, and telephone requests will not be honored. No award will be made on the basis of unsolicited quotations or offers received in response to this notice. Any response to this notice must show clear, compelling and convincing evidence that competition will be advantageous to the Government. The intent of this synopsis is for informational purposes only. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this action based on this notice is solely within the discretion of the Government.

All inquiries and concerns must be addressed in writing via e-mail to alexis.v.medrano.civ@health.mil and copy catherine-tehila.o.johnson.civ@health.mil with the following information referenced in the subject line, Respond to Notice of Intent (NOI) – Allergen Extract Supplies. A determination by the Government not to compete this proposed procurement based on the responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.

All interested parties must be able to meet the following specifications:

1. The contractor/manufacturer must be approved and licensed by the FDA and have no current outstanding violations with respect to appropriate FDA procedural and regulatory guidelines or policies.

2. The contractor/manufacturer’s facility will be compliant with USP regulations and recommended USP 797 guidelines. Manufacturer USP 797 adherence policies and procedures shall be made available to USACAEL upon request. Issues and concerns involving USP 797 guidelines will be addressed promptly.

3. The manufacturer/contractor shall supply the allergen extract products and ancillary supplies as specified with respect to concentrations dosage form (Aqueous or Glycerinated) and annual USACAEL volume usage requirements, there will be no deviations authorized.

4. The manufacturer/contractor must be able to supply at least 98% of requested allergen extract products, see attached listing of requested allergen extracts.

All interested parties who are responsible, certified, and capable may identify their interest and may submit an offer or quotation which shall be considered by the agency no later than 12:00 PM, Central Standard Time (CST) on March 4, 2025, to Alexis V. Medrano at alexis.v.medrano.civ@health.mil and alexis.v.medrano.civ@army.mil. Please copy catherine-tehila.o.johnson.civ@health.mil and catherine-tehila.o.johnson.civ@army.mil. The interested parties bear full responsibility to ensure complete transmission and timely receipt.

End of Document

File details come from the government source that posted it. Updated .